{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:08:40Z","timestamp":1781557720721,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.gassur.2024.01.023","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T21:19:58Z","timestamp":1706044798000},"page":"559-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-2167","authenticated-orcid":false,"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoran","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10272","key":"10.1016\/j.gassur.2024.01.023_bib1","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.gassur.2024.01.023_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gassur.2024.01.023_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/cco.2019.07.06","article-title":"Biliary tract cancer prognostic and predictive genomics","volume":"8","author":"Mondaca","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.gassur.2024.01.023_bib5","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2147\/CMAR.S157092","article-title":"Biliary tract cancers: current knowledge, clinical candidates and future challenges","volume":"11","author":"Tariq","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \u201cprime time\u201d in biliary tract cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100378","article-title":"How I treat biliary tract cancer","volume":"7","author":"Lamarca","year":"2022","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.gassur.2024.01.023_bib8","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2024.01.023_bib9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.ejca.2014.02.015","article-title":"Neutrophil\/lymphocyte ratio as a prognostic factor in biliary tract cancer","volume":"50","author":"Mcnamara","year":"2014","journal-title":"Eur J Cancer"},{"issue":"14","key":"10.1016\/j.gassur.2024.01.023_bib10","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.3390\/cancers13143594","article-title":"Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers","volume":"13","author":"Conci","year":"2021","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.gassur.2024.01.023_bib11","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033656","article-title":"Preoperative C-reactive protein-to-albumin ratio as a prognostic factor in biliary tract cancer: a systematic review and meta-analysis","volume":"102","author":"Utsumi","year":"2023","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-34962-7","article-title":"C-reactive protein\/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel","volume":"13","author":"Shirakawa","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.gassur.2024.01.023_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.annonc.2022.03.274","volume":"33","author":"Hacker","year":"2022","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.gassur.2024.01.023_bib14","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1111\/cas.15964","article-title":"Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy","volume":"114","author":"Huai","year":"2023","journal-title":"Cancer Sci"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib15","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.18632\/aging.202357","article-title":"Prognostic and clinical significance of modified Glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients","volume":"13","author":"Wu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.gassur.2024.01.023_bib16","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1080\/01635581.2021.1980591","article-title":"Prognostic value of pretreatment Glasgow prognostic score\/modified Glasgow prognostic score in ovarian cancer: a systematic review and meta-analysis","volume":"74","author":"Xu","year":"2022","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.gassur.2024.01.023_bib17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1159\/000495500","article-title":"Prognostic value of the Glasgow prognostic score or modified Glasgow prognostic score for patients with colorectal cancer receiving various treatments: a systematic review and meta-analysis","volume":"51","author":"He","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"10.1016\/j.gassur.2024.01.023_bib18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/01635581.2019.1677925","article-title":"The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a meta-analysis","volume":"72","author":"Wang","year":"2020","journal-title":"Nutr Cancer"},{"issue":"9","key":"10.1016\/j.gassur.2024.01.023_bib19","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.21873\/anticanres.11053","article-title":"Preoperative systemic inflammation and complications affect long-term gallbladder carcinoma outcomes following surgery with curative intent","volume":"36","author":"Abe","year":"2016","journal-title":"Anticancer Res"},{"issue":"2-3","key":"10.1016\/j.gassur.2024.01.023_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000521969","article-title":"Prognostic impact of inflammation-based scores for extrahepatic cholangiocarcinoma","volume":"39","author":"Asakura","year":"2022","journal-title":"Dig Surg"},{"issue":"6","key":"10.1016\/j.gassur.2024.01.023_bib21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5582\/bst.2020.03326","article-title":"The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer","volume":"14","author":"Bao","year":"2021","journal-title":"BioSci Trends"},{"issue":"3","key":"10.1016\/j.gassur.2024.01.023_bib22","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10637-017-0548-7","article-title":"Prognostic implication of inflammation-based prognostic scores in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin","volume":"36","author":"Cho","year":"2018","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.gassur.2024.01.023_bib23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jss.2019.01.033","article-title":"The comparison of inflammation-based prognostic scores in patients with extrahepatic bile duct cancer after pancreaticoduodenectomy","volume":"238","author":"Fujiwara","year":"2019","journal-title":"J Surg Res"},{"key":"10.1016\/j.gassur.2024.01.023_bib24","article-title":"Evaluation of preoperative inflammation-based prognostic scores in patients with intrahepatic cholangiocarcinoma: a multicenter cohort study","volume":"11","author":"He","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gassur.2024.01.023_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11605-018-3892-9","article-title":"Clinical value of inflammation-based prognostic scores to predict the resectability of hyperbilirubinemia patients with potentially resectable Hilar cholangiocarcinoma","volume":"23","author":"Hu","year":"2019","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-013-0787-1","article-title":"The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection","volume":"31","author":"Iwaku","year":"2014","journal-title":"Med Oncol"},{"issue":"5","key":"10.1016\/j.gassur.2024.01.023_bib27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejso.2019.12.008","article-title":"Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer \u2013 validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort","volume":"46","author":"Jansson","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.gassur.2024.01.023_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/bjs5.50348","article-title":"C-reactive protein: albumin ratio in patients with resectable intrahepatic cholangiocarcinoma","volume":"4","author":"Matsumoto","year":"2020","journal-title":"BJS Open"},{"issue":"3","key":"10.1016\/j.gassur.2024.01.023_bib29","first-page":"1755","article-title":"The modified Glasgow prognostic score in patients with gemcitabine-refractory biliary tract cancer","volume":"38","author":"Okano","year":"2018","journal-title":"Anticancer Res"},{"issue":"10","key":"10.1016\/j.gassur.2024.01.023_bib30","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jhbp.386","article-title":"Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma","volume":"23","author":"Okuno","year":"2016","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07482-0","article-title":"The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy","volume":"20","author":"Sun","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.gassur.2024.01.023_bib32","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.21873\/anticanres.14987","article-title":"Comparison of inflammation-based prognostic scores in patients with biliary tract cancer after surgical resection","volume":"41","author":"Utsumi","year":"2021","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-022-02783-z","article-title":"Prognostic role of the systemic immune-inflammation index in biliary tract cancers: a meta-analysis of 3,515 patients","volume":"20","author":"Zhang","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"11","key":"10.1016\/j.gassur.2024.01.023_bib35","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1007\/s00262-023-03513-4","volume":"72","author":"Zhang","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.gassur.2024.01.023_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","article-title":"C-reactive protein: ligands, receptors and role in inflammation","volume":"117","author":"Marnell","year":"2005","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.gassur.2024.01.023_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00404-020-05581-8","article-title":"A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis","volume":"301","author":"Nie","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.gassur.2024.01.023_bib38","article-title":"C-reactive protein is an indicator of the immunosuppressive microenvironment fostered by myeloid cells in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.gassur.2024.01.023_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071966","article-title":"Combined C-reactive protein and novel inflammatory parameters as a predictor in cancer-what can we learn from the hematological experience?","volume":"12","author":"Bruserud","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.gassur.2024.01.023_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2019.10.031","article-title":"Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study","volume":"133","author":"Eckart","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.gassur.2024.01.023_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.707705","article-title":"Evaluation and validation of the prognostic value of serum albumin to globulin ratio in patients with cancer cachexia: results from a large multicenter collaboration","volume":"11","author":"Xie","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.gassur.2024.01.023_bib42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1207\/S15327914nc392_8","article-title":"Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss","volume":"39","author":"Mcmillan","year":"2001","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.gassur.2024.01.023_bib43","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hep.27644","article-title":"Prostaglandin E2-mediated immunosuppression and the role of albumin as its modulator","volume":"61","author":"Choe","year":"2015","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gassur.2024.01.023_bib44","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/sj.bjc.6601789","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer","volume":"90","author":"Forrest","year":"2004","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.gassur.2024.01.023_bib45","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"Mcmillan","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.gassur.2024.01.023_bib46","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.bjc.6606087","article-title":"An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study","volume":"104","author":"Proctor","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.gassur.2024.01.023_bib47","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ygyno.2017.10.019","article-title":"Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) \u2013 analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)","volume":"148","author":"Roncolato","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.gassur.2024.01.023_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184412","article-title":"Clinical utility of the modified Glasgow prognostic score in lung cancer: a meta-analysis","volume":"12","author":"Jin","year":"2017","journal-title":"PLoS One"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24001331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X24001331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T12:09:09Z","timestamp":1733227749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X24001331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1091255X24001331"],"URL":"https:\/\/doi.org\/10.1016\/j.gassur.2024.01.023","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gassur.2024.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of Society for Surgery of the Alimentary Tract.","name":"copyright","label":"Copyright"}]}}